TO EVALUATE THE EFFICIENCY AND SAFETY OF PRUTNYAK IN THE TREATMENT OF HYPERPROLACTINEMIA. (2022). Archive of Conferences, 171-172. https://conferencepublication.com/index.php/aoc/article/view/2204